Companies: 10,795·Total market cap: $144.5T
Sartorius Stedim Biotech S.A.

Sartorius Stedim Biotech S.A.

SRTOYOTCHealthcare● Active
$20.73
+$0.21(+1.01%)
Market Cap$201.6B
P/E Ratio—
52W High$26.54
52W Low$17.25
PE RatioMarket CapForecast

Sartorius Stedim Biotech S.A. (SRTOY) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

srtoy · pe ratio · data through Jun 10, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

Insufficient PE history data (fewer than 3 valid fiscal years).

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Sartorius Stedim Biotech S.A. (SRTOY) measures how much investors pay for each dollar of the company's trailing earnings. SRTOY's current PE ratio of N/A is calculated by dividing its stock price of $20.73 by its TTM earnings per share of —.

PE Ratio = Stock Price ÷ EPS (TTM)
= $20.73 ÷ — = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.
Price historyFinancial statementsEarnings

Frequently asked questions

SRTOY pe ratio · 6 questions

SRTOY's current PE ratio is N/A as of 2026-06-10, based on a stock price of $20.73 and TTM EPS of —. Data sourced from Financial Modeling Prep via SRTOY's SEC 10-K and 10-Q filings.

SRTOY PE ratioWhat is SRTOY PE ratioCurrent PE ratio of SRTOYSRTOY PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Sartorius Stedim Biotech S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10